Inhibiting the transient receptor potential A1 ion channel

• 收藏
• 分享

专利权人:

Eli Lilly and Company

发明人:

WU, Xinyuan

申请号：

AU2019216247

公开号：

AU2019216247A1

申请日:

2019.01.30

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The present invention relates to pharmaceutical compounds of the Formula (I), or a pharmaceutically acceptable salt or composition thereof, and methods of their use for the treatment of pain, respiratory conditions, as well as inhibiting the Transient Receptor Potential Al ion channel (TRPA1).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/